Zymeworks BC Inc.
DelistedCIK 1403752fmd_1R03EP9YZAFJ7Q8E9E6D4Q5KJ5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Jun 30, 2022, 23 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|
| Total revenues | 11 | 52 | 53 | 30 | 39 | 27 |
| Research and development | 37 | 42 | 57 | 117 | 171 | 200 |
| Operating income | (38) | (9) | (33) | (151) | (187) | (216) |
| Interest and investment income | 0 | 1 | 3 | 6 | 6 | – |
| Other non-operating income (expense) | (1) | (0) | (1) | (1) | 2 | 1 |
| Income before taxes | (39) | (10) | (34) | (146) | (180) | (212) |
| Income tax expense | (5) | 0 | 2 | (1) | 0 | (1) |
| Net income from continuing operations | (34) | (10) | (37) | (145) | (181) | (212) |
| Net income | (34) | (10) | (37) | (145) | (181) | (212) |
| Net income to common shareholders | (34) | (11) | (37) | (145) | (181) | (212) |